529 related articles for article (PubMed ID: 33629412)
1. The use of fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography as an effective method for staging in dogs with primary appendicular osteosarcoma.
Crooks C; Randall E; Griffin L
Vet Radiol Ultrasound; 2021 May; 62(3):350-359. PubMed ID: 33629412
[TBL] [Abstract][Full Text] [Related]
2. Staging canine patients with appendicular osteosarcoma utilizing fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography compared to whole body computed tomography.
Brody A; Crooks JC; French JM; Lang LG; Randall EK; Griffin LR
Vet Comp Oncol; 2022 Sep; 20(3):541-550. PubMed ID: 35166445
[TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis of use of fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography (
Slinkard PT; Randall EK; Griffin LR
Can J Vet Res; 2021 Apr; 85(2):131-136. PubMed ID: 33883821
[TBL] [Abstract][Full Text] [Related]
4. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
Aryal A; Kumar VS; Shamim SA; Gamanagatti S; Khan SA
Clin Orthop Relat Res; 2021 Aug; 479(8):1768-1779. PubMed ID: 33635285
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of fluorine
Griffin LR; Thamm DH; Brody A; Selmic LE
J Vet Intern Med; 2019 Mar; 33(2):820-826. PubMed ID: 30768736
[TBL] [Abstract][Full Text] [Related]
6. Retrospective Evaluation of Whole Body Computed Tomography for Tumor Staging in Dogs with Primary Appendicular Osteosarcoma.
Talbott JL; Boston SE; Milner RJ; Lejeune A; Souza CH; Kow K; Bacon NJ; Hernandez JA
Vet Surg; 2017 Jan; 46(1):75-80. PubMed ID: 27906470
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma.
Hurley C; McCarville MB; Shulkin BL; Mao S; Wu J; Navid F; Daw NC; Pappo AS; Bishop MW
Pediatr Blood Cancer; 2016 Aug; 63(8):1381-6. PubMed ID: 27082077
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of metabolic tumour volume and total lesion glycolysis for dogs staged for appendicular osteosarcoma with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Griffin LR; Brody A; Lee BI
Vet Comp Oncol; 2022 Mar; 20(1):59-68. PubMed ID: 33988286
[TBL] [Abstract][Full Text] [Related]
10. The impact of
Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A
Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of
Liu F; Zhang Q; Zhou D; Dong J
BMC Cancer; 2019 Apr; 19(1):323. PubMed ID: 30953476
[TBL] [Abstract][Full Text] [Related]
12. [
Metser U; Kulanthaivelu R; Salawu A; Razak A; Mak V; Li X; Langer DL; MacCrostie P; Singnurkar A
J Nucl Med; 2023 Sep; 64(9):1371-1377. PubMed ID: 37414444
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study.
Borgatti A; Winter AL; Stuebner K; Scott R; Ober CP; Anderson KL; Feeney DA; Vallera DA; Koopmeiners JS; Modiano JF; Froelich J
PLoS One; 2017; 12(2):e0172651. PubMed ID: 28222142
[TBL] [Abstract][Full Text] [Related]
14.
Grobman M; Cohn L; Knapp S; Bryan JN; Reinero C
Vet Radiol Ultrasound; 2018 Jan; 59(1):107-115. PubMed ID: 28925085
[TBL] [Abstract][Full Text] [Related]
15. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis.
Liu F; Zhang Q; Zhu D; Liu F; Li Z; Li J; Wang B; Zhou D; Dong J
Medicine (Baltimore); 2015 Sep; 94(36):e1462. PubMed ID: 26356700
[TBL] [Abstract][Full Text] [Related]
16. The relation between staging fluorine-18 fluorodeoxyglucose positron emission tomog- raphy/computed tomography metabolic parameters and tumor necrosis rate in pediatric osteosarcoma patients.
Fidan AK; Uçmak G; Demirel BB; Efetürk H; Öztürk İ; Demirtaş Şenlik S; Esen Akkaş B; Ergürhan İlhan İ
Turk J Med Sci; 2021 Jun; 51(3):1115-1122. PubMed ID: 33387988
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of accuracy for
Willcox JL; Spriet M; Zwingenberger AL; Phillips KL; Burton JH; Skorupski KA; Hansen KS; Affolter VK; Woolard KD; Beylin D; Giuffrida MA
Vet Comp Oncol; 2021 Sep; 19(3):463-472. PubMed ID: 32892513
[TBL] [Abstract][Full Text] [Related]
18. Pilot study utilizing Fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography for glycolytic phenotyping of canine mast cell tumors.
Griffin LR; Thamm DH; Selmic LE; Ehrhart EJ; Randall E
Vet Radiol Ultrasound; 2018 Jul; 59(4):461-468. PubMed ID: 29570234
[TBL] [Abstract][Full Text] [Related]
19. Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography for staging of canine insulinoma: 3 cases (2019-2020).
Walczak R; Kawalilak L; Griffin L
J Small Anim Pract; 2022 Mar; 63(3):227-233. PubMed ID: 34811734
[TBL] [Abstract][Full Text] [Related]
20. Utility of positron emission tomography/computed tomography (PET/CT) imaging in the evaluation of sarcomas: A systematic review.
Lim HJ; Johnny Ong CA; Tan JW; Ching Teo MC
Crit Rev Oncol Hematol; 2019 Nov; 143():1-13. PubMed ID: 31449981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
